MATTHEW KESSLER: Open Payments
NPI 1629798806 · LANCASTER, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$275 in 15 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $14 · 2025 $275
Food & beverage: $275
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 4 | $73 |
| PFIZER INC. | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| Dexcom, Inc. | 1 | $22 |
| SHIELD THERAPEUTICS INC | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| ABBVIE INC. | 1 | $15 |
| Exact Sciences Corporation | 1 | $14 |
| Novo Nordisk Inc | 1 | $14 |
Products named: GVOKE HYPOPEN, ELIQUIS, AIRSUPRA, CAPLYTA, Dexcom G6 Transmitter, ACCRUFER, REXULTI, CREON.
Industry payments across OH — which companies pay providers there.
